Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,252
Award facts
- Contract value 100% obligated
- $20,252.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,252.24 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Dupixent 300 mg/2 ml pen injectors with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, and represents a critical pharmaceutical supply for military healthcare programs.
This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Amerisourcebergen operates as a major pharmaceutical distributor and healthcare solutions provider, supplying an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's capability to fulfill this pharmaceutical supply order demonstrates its established role in supporting the military medical supply chain through competitive federal contracting.
Quick answers
Who was awarded contract SPE2DR26FFL0Q?
SPE2DR26FFL0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FFL0Q worth?
The government has obligated $20,252 on SPE2DR26FFL0Q.
Is contract SPE2DR26FFL0Q an order under another contract?
Yes. SPE2DR26FFL0Q is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL0Q competed?
The extent of competition for SPE2DR26FFL0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award